Fortune | FORTUNE 2024年10月14日
Who should, and shouldn’t, sign up for the new Medicare Prescription Payment Plan
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

Medicare Prescription Payment Program (M3P) 旨在帮助 Medicare 受益者在一年中更均匀地支付处方药费用,避免在特定月份出现高昂的药物支出。M3P 是通过 Inflation Reduction Act of 2022 推出的,旨在解决 Medicare 受益者在购买昂贵品牌药物或在年初达到 Part D 计划免赔额之前承担高额自付费用所面临的挑战。该计划通过将处方药费用分摊到每个月,旨在帮助受益者更好地管理他们的药物费用。然而,M3P 并非适合所有人,其适用性取决于个人处方药费用模式和财务状况。

💊 **M3P 的工作原理:**M3P 将处方药费用分摊到每个月,而不是一次性支付。每月账单将包括该月处方药费用以及上个月的余额,除以剩余月份数。这意味着每月费用会根据处方药的类型、用药频率、开始时间、是否停药以及药物价格而有所不同。

🤔 **谁应该考虑 M3P?**M3P 对于以下人群可能是有益的:预计在 2025 年前 9 个月内自付 Part D 处方药费用超过 2,000 美元的人;在任何一个月内自付 Part D 处方药费用超过 600 美元的人;拥有高 Part D 免赔额并希望将其平均分配到一年中的人;每月慢性病药物自付费用超过 250 美元的人。

🚫 **谁应该避免 M3P?**以下人群可能不会从 M3P 中获益:年度药物费用较低的人;每月自付 Part D 处方药费用相同的人;能够管理每月自付 Part D 处方药费用的人;通过 Medicare 的 Extra Help 计划、Medicare Savings Programs 或类似计划获得 Part D 补贴的人;在 2025 年 9 月之后注册的人。

⚠️ **潜在问题:**M3P 的一个潜在问题是,在年底可能会出现意外的账单,因为每月费用会根据当月的处方药费用和上个月的余额进行计算。此外,如果在注册 M3P 之前已经支付了 2,000 美元的自付费用,M3P 可能会导致在年底出现更高的每月费用。

💡 **如何使用 Medicare 的 Plan Finder 工具:**Medicare 的 Plan Finder 工具可以帮助你了解 M3P 对你个人处方药费用的影响。你可以输入你的处方药和首选药房,然后查看不同的 Part D 计划。在“Plan Details”页面中,你会找到“Yearly Drug Costs By Pharmacy”一栏,其中包含 M3P 的说明以及使用 M3P 后你的药物费用可能如何变化。

📝 **建议:**在注册 M3P 之前,仔细评估你的个人处方药费用模式和财务状况。如果你不确定 M3P 是否适合你,请咨询你的医生或药剂师。

There’s one question people over 65 will need to answer for the first time during Medicare Open Enrollment (October 15 to December 7): Should I sign up for the optional, new and little-known Medicare Prescription Payment Program for 2025?Like so many things about Medicare, making the decision is not simple.“It’s complicated and it’s nuanced,” says Amy Niles, Chief Mission Officer of The PAN Foundation, a health care affordability and accessibility nonprofit. “Generally speaking, it is a very good reform, but it is not for everybody.”Why the Medicare Prescription Payment Program was createdThe Medicare Prescription Payment Program—or M3P as it’s been dubbed—was put into the Inflation Reduction Act of 2022 to help Medicare beneficiaries avoid being socked with steep drug costs during certain months of the year.Beneficiaries can encounter that problem either when they take expensive brand name drugs or have high out-of-pocket costs early in the year because they haven’t yet reached their Part D plan deductible.A 2023 study published in JAMA Network Open found that 20% of Medicare beneficiaries didn’t take or get their prescriptions because they couldn’t afford them. The health research group KFF estimates that 5 million Medicare beneficiaries with Part D plans had out-of-pocket prescription drug costs of $2,000 or more in at least one year between 2012 and 2021.How you’ll pay for prescriptions with the Medicare Prescription Payment ProgramIf you sign up for M3P with the Part D prescription plan you choose for 2025—a standalone plan or one that’s part of a private insurer’s Medicare Advantage plan—you won’t pay for medications at the pharmacy. Instead, you’ll get a monthly bill for them from your Part D plan as well as its monthly premium, if there is one.The promise of M3P is “smoothing” out monthly prescription costs throughout the year for people who could use the help to afford their medications.“The result of the Medicare Prescription Payment Plan is going to be more seniors being able to pick up their prescriptions next year,” says Brian Whorley, CEO of Paytient, a company handling the software for about 40% of the nation’s Part D plans. “This is going to expand access, improve affordability and people are going to be more adherent.”The public seems unaware of the new payment programThat assumes people know about the program. Many apparently don’t.“We went to a pharmacy in my hometown of Columbia, Missouri, and asked folks: ‘Have you heard of this thing called the Medicare Prescription Payment Program?’ And no one knew anything about this,” says Whorley.Medicare’s new Medicare & You 2025 booklet for beneficiaries doesn’t mention M3P until page 83, and only for two paragraphs there.Some Medicare beneficiaries may mistakenly believe enrolling in the Prescription Payment Program will reduce their drug costs.“This is not a cost-reduction program. It’s a cost-shifting program,” says Casey Schwarz, Senior Counsel for Education and Federal Policy at the Medicare Rights Center.As Medicare’s site says in bold type: This payment option might help you manage your expenses, but it doesn’t save you money or lower your drug costs.“Some people may see a significant benefit from the ability to shift their costs throughout the year. Others won’t see as much of a benefit,” Schwarz says. “And it may even be worse for their financial planning, depending on how they encounter their drug costs throughout the year and their expected financial situation through the year.”As Georgia Gerdes, a Senior Training Specialist at the AgeOptions Area Agency on Aging in the Chicago suburbs, says: “My key takeaway is the Medicare Prescription Payment Program is not a one-size-fits-all program.”The payment plan’s payment formulaTo understand who should or shouldn’t consider signing up for M3P and how enrolling could even make your monthly out-of-pocket expenses rise at the end of 2025, you need to understand how the “smoothing” formula will work.Since Medicare will cap out-of-pocket Part D prescription costs at $2,000 in 2025 (the cap doesn’t apply to prescriptions not covered by your plan, Part B medications received at a doctor’s office or Part B medical devices like continuous glucose monitors), you might think that M3P would just even out your maximum outlay at $167 every month, which is $2,000 divided by 12.You’d be mistaken.Instead, the rolling formula all Part D plans will use for monthly bills of people with M3P is this: What you would have paid for any prescriptions that month plus your previous month’s balance divided by the number of months left in the year.That means your monthly cost will vary depending on which prescriptions you’ve taken, how regularly, when you started them, whether you stopped them and how much they cost.In other words, despite the program’s “smoothing” tag, you likely won’t be spending exactly the same amount every month.Worries about surprise bills at year-end“The concern I have is folks who have relatively stable drug costs signing up for the payment program. It will, in fact, make them less stable. And we don’t want to see folks with a surprise increase in costs as the year goes on,” says Schwarz.Dusetzina believes large surprise bills at the end of the year may be an unintended consequence of M3P.The Medicare site has a useful section explaining the Medicare Prescription Payment Plan and its Plan Finder tool lets you see what your monthly prescription costs would be with M3P for any Part D plan where you live.Here’s how: After plugging in your prescriptions and preferred pharmacies, you look up a plan, go to “Plan Details” and after “Yearly Drug Costs By Pharmacy,” you’ll find an explanation of The Medicare Prescription Payment Plan, details about it and what your drug costs might look like if you use it.You may find that your monthly costs with the plan will differ from one Part D plan to another depending on how much each charges for each of your prescriptions, says Gerdes.Medicare’s Plan Finder also has a new tool to help you determine whether M3P would help you. It asks five simple questions about your drug costs and then explains whether the payment program would likely help you.Who should and shouldn’t consider the Medicare Prescription Payment ProgramThe types of people who’d be most likely to benefit by signing up for M3P are:Those who’ll have more than $2,000 in out-of-pocket Part D prescription costs in the first nine months of 2025Those who’ll owe more than $600 in a single Part D prescription cost in any monthThose who have high Part D deductibles and want to smooth them out over the yearAn analysis in Health Affairs by Vanderbilt Professor of Health Policy Stacie Dusetzina also found M3P could be useful for people with out-of-pocket costs of $250 a month for chronic-disease medications starting in January.“This is the type of person who would be least likely to have any downside from enrolling in the plan,” Dusetzina tells Fortune. “You’ll hit that out-of-pocket maximum of $2,000 early enough in the year that you never barely go over $250 with the payment plan.”The types of people who’d be least likely to benefit by signing up for M3P are:Those whose yearly drug costs are lowThose whose out-of-pocket Part D prescription costs are the same every month (since there’s nothing for them to smooth out)Those who can manage their monthly out-of-pocket Part D prescription costsThose who get Part D subsidies through Medicare’s Extra Help plan for people with limited income (under roughly $23,000; $31,000 for married couples) and resources, or Medicare Savings Programs or similar programs drug companies and groups like The PAN FoundationThose who sign up after September 2025“If you take a bunch of fairly low-cost generic pills and you’re nowhere near the $2,000 cap, as long as you have money in your bank account and budget, the payment plan is probably not worth it at all,” says Niles.If your Part D plan sees that you incurred $2,000 or more in out-of-pocket prescription costs in 2024, it must let you know that you’re likely to benefit with M3P.What could happen at the drugstoreAnd if you will owe $600 or more for a prescription at the drugstore and haven’t enrolled in M3P, your pharmacy is supposed to tell you about the payment plan and give you a “Likely to Benefit Notice.”But, Dusetzina says, “pharmacists are very, very busy and it’s very difficult for them to spend a lot of time with you.”And if your conversation with the pharmacist persuades you to sign up for M3P, get ready for this: You’ll probably need to leave without the medication, go home to fill out the form and then return to the pharmacy to pick up the prescription.You can sign up for the Medicare Prescription Payment Program any time, but you get the most help from it by doing so during Open Enrollment. That way, your out-of-pocket costs will be smoothed out throughout the entire year.The payment plan could work against if you begin enrolling late in 2025 and haven’t yet spent $2,000 in Part D costs.That’s because with the M3P formula, says Schwarz, “every month you have not hit your out-of-pocket maximum of $2,000 and you’re adding to your drug costs, you are adding to the amount that is then spread over the remaining months of the year and that number of remaining months is getting shorter.”Says Dusetzina: “One of the things that’s going to be really annoying is if your prescription-drugs’ price ends up going up to a couple of hundred dollars or $300 or more towards the end of the year as you’re getting into the holidays and maybe want to spend a little of that money to travel and see family or buy people gifts.”If you are filling prescriptions and you’re on the payment plan and didn’t hit the $2,000 cap, it could have a really weird effect where you keep adding money to your outstanding balance. So, some consumers taking one or two brand-name drugs every month might actually find themselves having bills that look like they’re going up.”2 prescription plan bills, not 1Another wrinkle in M3P: Since you won’t be paying for the prescriptions at the drugstore or by mail order, you’ll get a bill for them each month from your Part D plan. That’s in addition to the bill you’ll likely get from the insurer for its Part D premium.“If an individual is having a hard time paying two bills, we’re advising to always pay your premium bill first, because you want to protect your coverage,” says Niles. A two months’ late MP3 payment will take you off that program but won’t boot you off your Part D plan.Where to get helpTo get help deciding whether to sign up for the Medicare Prescription Payment plan or get financial assistance elsewhere, you could ask a free, objective Medicare expert at your State Health Insurance Assistance Program (SHIP).You could also talk with your pharmacist or your Medicare broker, if you use one. “The pharmacist is going to be able to help you think about the many ways you could address the problem of having difficulty affording your medicine,” says Dusetzina.The PAN Foundation’s website has a useful section explaining the Medicare Prescription Payment Plan, too.Experts expect the rollout of the smoothing payment plan will not be smooth.“It’s going to be rocky and we’ll just do the best we can with it and learn from it,” said Niles.More on Medicare:

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

Medicare 处方药 Medicare Prescription Payment Program M3P 自付费用 药物费用 健康保险 老年人
相关文章